• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cas11增强了I-E型CRISPR系统中的Cascade功能,但在基因沉默和质粒干扰方面是多余的。

Cas11 augments Cascade functions in type I-E CRISPR system but is redundant for gene silencing and plasmid interference.

作者信息

Pandey Neha, Misra Chitra Seetharam, Rath Devashish

机构信息

Applied Genomics Section, Bio-Science Group, Bhabha Atomic Research Centre, Mumbai, India.

Life Sciences, Mumbai University, Vidya Nagari, Kalina, Santacruz East, Mumbai, India.

出版信息

Biochem J. 2025 Jun 11;482(12):BCJ20253056. doi: 10.1042/BCJ20253056.

DOI:10.1042/BCJ20253056
PMID:40401996
Abstract

The structural and mechanistic complexity of Escherichia coli's type I Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated (CRISPR-Cas) system, compared with the multidomain, single effector protein-based type II systems, limits its application in genome editing and silencing. Despite the higher prevalence of the type I endogenous systems in bacteria, significant research has focused on improving the type II systems. While the type-I CRISPR system possesses several advantages over others, it may benefit from further studies to simplify the system for ease of use. To enable this, the dispensability of the type-I Cascade components (Cas8, Cas11, Cas7, Cas5 and Cas6) for genome editing and silencing applications was evaluated in vivo. We created deletion variants of each of the Cascade components and investigated their effects on gene silencing and plasmid interference in two genetically distinct E. coli lineages: BW25113, a K-12 strain that bears an endogenous, albeit repressed type I-E CRISPR system; and BL21, a natural mutant lacking the type I-E CRISPR-Cas system. Cas8, Cas7 and Cas5 were found to be indispensable for gene silencing and plasmid interference. Dispensability of Cas6, which is involved in crRNA maturation, was strain-dependent. Notably, Cas11, which has no definitive function assigned to it, was found to be dispensable for gene silencing and plasmid interference.

摘要

与基于多结构域单效应蛋白的II型系统相比,大肠杆菌I型成簇规律间隔短回文重复序列/CRISPR相关(CRISPR-Cas)系统的结构和机制复杂性限制了其在基因组编辑和沉默中的应用。尽管I型内源系统在细菌中更为普遍,但大量研究都集中在改进II型系统上。虽然I型CRISPR系统比其他系统具有一些优势,但进一步研究以简化该系统以便于使用可能会使其受益。为此,在体内评估了I型Cascade组件(Cas8、Cas11、Cas7、Cas5和Cas6)在基因组编辑和沉默应用中的必要性。我们创建了每个Cascade组件的缺失变体,并在两个遗传背景不同的大肠杆菌谱系中研究了它们对基因沉默和质粒干扰的影响:BW25113,一种K-12菌株,带有内源性的I-E型CRISPR系统,尽管该系统受到抑制;以及BL21,一种缺乏I-E型CRISPR-Cas系统的天然突变体。发现Cas8、Cas7和Cas5对于基因沉默和质粒干扰是不可或缺的。参与crRNA成熟的Cas6的必要性因菌株而异。值得注意的是,尚未赋予明确功能的Cas11被发现对于基因沉默和质粒干扰是可有可无的。

相似文献

1
Cas11 augments Cascade functions in type I-E CRISPR system but is redundant for gene silencing and plasmid interference.Cas11增强了I-E型CRISPR系统中的Cascade功能,但在基因沉默和质粒干扰方面是多余的。
Biochem J. 2025 Jun 11;482(12):BCJ20253056. doi: 10.1042/BCJ20253056.
2
Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation in the Type I-E CRISPR-Cas System.确定 I 型-E CRISPR-Cas 系统中级联结合、干扰和引物适应的特异性。
mBio. 2018 Apr 17;9(2):e02100-17. doi: 10.1128/mBio.02100-17.
3
Biochemical plasticity of the Escherichia coli CRISPR Cascade revealed by in vitro reconstitution of Cascade activities from purified Cas proteins.通过从纯化的Cas蛋白体外重建Cascade活性揭示大肠杆菌CRISPR Cascade的生化可塑性
FEBS J. 2024 Dec;291(23):5177-5194. doi: 10.1111/febs.17295. Epub 2024 Oct 7.
4
CRISPR/dCas-mediated counter-silencing: reprogramming dCas proteins into antagonists of xenogeneic silencers.CRISPR/dCas介导的反沉默:将dCas蛋白重编程为异种沉默子的拮抗剂。
mBio. 2025 Jul 9;16(7):e0038225. doi: 10.1128/mbio.00382-25. Epub 2025 May 28.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Type I-E* CRISPR-Cas of upregulates bacterial virulence by targeting endogenous histidine utilization system.I-E*型CRISPR-Cas通过靶向内源性组氨酸利用系统上调细菌毒力。
mSphere. 2025 Jun 25;10(6):e0021525. doi: 10.1128/msphere.00215-25. Epub 2025 May 19.
7
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
10
Single-incision sling operations for urinary incontinence in women.女性尿失禁的单切口吊带手术
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD008709. doi: 10.1002/14651858.CD008709.pub3.

本文引用的文献

1
Biochemical plasticity of the Escherichia coli CRISPR Cascade revealed by in vitro reconstitution of Cascade activities from purified Cas proteins.通过从纯化的Cas蛋白体外重建Cascade活性揭示大肠杆菌CRISPR Cascade的生化可塑性
FEBS J. 2024 Dec;291(23):5177-5194. doi: 10.1111/febs.17295. Epub 2024 Oct 7.
2
Effective gene silencing using type I-E CRISPR system in the multiploid, radiation-resistant bacterium .在多倍体、抗辐射细菌中使用I-E型CRISPR系统实现有效的基因沉默
Microbiol Spectr. 2023 Sep 6;11(5):e0520422. doi: 10.1128/spectrum.05204-22.
3
Type I-E CRISPR-Cas System as a Defense System in Saccharomyces cerevisiae.
I 型-E CRISPR-Cas 系统作为酿酒酵母中的防御系统。
mSphere. 2022 Jun 29;7(3):e0003822. doi: 10.1128/msphere.00038-22. Epub 2022 Apr 27.
4
Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems.Cas11 使紧凑型 CRISPR-Cas3 系统能够在人类细胞中进行基因组工程。
Mol Cell. 2022 Feb 17;82(4):852-867.e5. doi: 10.1016/j.molcel.2021.12.032. Epub 2022 Jan 19.
5
CRISPR/Cas System and Factors Affecting Its Precision and Efficiency.CRISPR/Cas系统及其影响精度和效率的因素
Front Cell Dev Biol. 2021 Nov 24;9:761709. doi: 10.3389/fcell.2021.761709. eCollection 2021.
6
Diverse CRISPR-Cas Complexes Require Independent Translation of Small and Large Subunits from a Single Gene.多种 CRISPR-Cas 复合物需要从单个基因独立翻译小亚基和大亚基。
Mol Cell. 2020 Dec 17;80(6):971-979.e7. doi: 10.1016/j.molcel.2020.11.003. Epub 2020 Nov 27.
7
Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.CRISPR-Cas 系统的进化分类:Class 2 及其衍生变体的爆发。
Nat Rev Microbiol. 2020 Feb;18(2):67-83. doi: 10.1038/s41579-019-0299-x. Epub 2019 Dec 19.
8
Characterization and repurposing of the endogenous Type I-F CRISPR-Cas system of Zymomonas mobilis for genome engineering.解析和再利用运动发酵单胞菌内源性 I 型 CRISPR-Cas 系统用于基因组工程。
Nucleic Acids Res. 2019 Dec 2;47(21):11461-11475. doi: 10.1093/nar/gkz940.
9
Origins and evolution of CRISPR-Cas systems.CRISPR-Cas 系统的起源与演化。
Philos Trans R Soc Lond B Biol Sci. 2019 May 13;374(1772):20180087. doi: 10.1098/rstb.2018.0087.
10
CRISPR-Cas-Mediated Gene Silencing Reveals RacR To Be a Negative Regulator of YdaS and YdaT Toxins in K-12.CRISPR-Cas介导的基因沉默揭示RacR是K-12中YdaS和YdaT毒素的负调控因子。
mSphere. 2017 Nov 22;2(6). doi: 10.1128/mSphere.00483-17. eCollection 2017 Nov-Dec.